BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34250910)

  • 1. Molecular Diagnosis of Monogenic Diabetes and Their Clinical/Laboratory Features in Turkish Children.
    Gökşen D; Yeşilkaya E; Özen S; Kor Y; Eren E; Korkmaz Ö; Berberoğlu M; Karagüzel G; Er E; Abacı A; Evliyaoğlu O; Akbaş ED; Ünal E; Bolu S; Nalbantoğlu Ö; Anık A; Tayfun M; Büyükinan M; Abalı S; Can Yılmaz G; Kor D; Söbü E; Şıklar Z; Polat R; Darcan Ş
    J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):433-438. PubMed ID: 34250910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Application of Next Generation Sequencing Maturity Onset Diabetes of the Young Gene Panel in Turkish Patients from Trakya Region.
    Yalçıntepe S; Özgüç Çömlek F; Gürkan H; Demir S; Atlı Eİ; Atlı E; Eker D; Tütüncüler Kökenli F
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):320-331. PubMed ID: 33565752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey.
    Haliloglu B; Hysenaj G; Atay Z; Guran T; Abalı S; Turan S; Bereket A; Ellard S
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):393-9. PubMed ID: 27256595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of Mutations in Maturity-onset Diabetes of the Young-related Genes and
    Şimşek E; Çilingir O; Şimşek T; Kocagil S; Erzurumluoğlu Gökalp E; Demiral M; Binay C
    J Clin Res Pediatr Endocrinol; 2024 May; 16(2):137-145. PubMed ID: 38054414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and Clinical Characterization of Patients with Maturity-Onset of Diabetes of the Young (MODY): Identification of Novel Variations.
    Ateş EA; Üstay Ö; Polat H; Apaydın T; Elbasan O; Yıldırım Ö; Güney Aİ
    Balkan Med J; 2021 Sep; 38(5):272-277. PubMed ID: 34462253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals.
    Bansal V; Gassenhuber J; Phillips T; Oliveira G; Harbaugh R; Villarasa N; Topol EJ; Seufferlein T; Boehm BO
    BMC Med; 2017 Dec; 15(1):213. PubMed ID: 29207974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy.
    Tatsi EB; Kanaka-Gantenbein C; Scorilas A; Chrousos GP; Sertedaki A
    Pediatr Diabetes; 2020 Feb; 21(1):28-39. PubMed ID: 31604004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monogenic Childhood Diabetes: Dissecting Clinical Heterogeneity by Next-Generation Sequencing in Maturity-Onset Diabetes of the Young.
    Demirci DK; Darendeliler F; Poyrazoglu S; Al ADK; Gul N; Tutuncu Y; Gulfidan G; Arga KY; Cacina C; Ozturk O; Aydogan HY; Satman I
    OMICS; 2021 Jul; 25(7):431-449. PubMed ID: 34171966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturity onset diabetes of youth (MODY) in Turkish children: sequence analysis of 11 causative genes by next generation sequencing.
    Ağladıoğlu SY; Aycan Z; Çetinkaya S; Baş VN; Önder A; Peltek Kendirci HN; Doğan H; Ceylaner S
    J Pediatr Endocrinol Metab; 2016 Apr; 29(4):487-96. PubMed ID: 26669242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing identifies monogenic diabetes in 16% of patients with late adolescence/adult-onset diabetes selected on a clinical basis: a cross-sectional analysis.
    Donath X; Saint-Martin C; Dubois-Laforgue D; Rajasingham R; Mifsud F; Ciangura C; Timsit J; Bellanné-Chantelot C;
    BMC Med; 2019 Jul; 17(1):132. PubMed ID: 31291970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes.
    Ming-Qiang Z; Yang-Li D; Ke H; Wei W; Jun-Fen F; Chao-Chun Z; Guan-Ping D
    J Pediatr Endocrinol Metab; 2019 Jul; 32(7):759-765. PubMed ID: 31216263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HNF1A gene p.I27L is associated with early-onset, maturity-onset diabetes of the young-like diabetes in Turkey.
    Beysel S; Eyerci N; Pinarli FA; Kizilgul M; Ozcelik O; Caliskan M; Cakal E
    BMC Endocr Disord; 2019 May; 19(1):51. PubMed ID: 31109344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis of maturity-onset diabetes of the young (MODY) in Turkish children by using targeted next-generation sequencing.
    Anık A; Çatlı G; Abacı A; Sarı E; Yeşilkaya E; Korkmaz HA; Demir K; Altıncık A; Tuhan HÜ; Kızıldağ S; Özkan B; Ceylaner S; Böber E
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1265-71. PubMed ID: 26226118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach.
    Alkorta-Aranburu G; Carmody D; Cheng YW; Nelakuditi V; Ma L; Dickens JT; Das S; Greeley SAW; Del Gaudio D
    Mol Genet Metab; 2014 Dec; 113(4):315-320. PubMed ID: 25306193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MODY in Ukraine: genes, clinical phenotypes and treatment.
    Globa E; Zelinska N; Elblova L; Dusatkova P; Cinek O; Lebl J; Colclough K; Ellard S; Pruhova S
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1095-1103. PubMed ID: 28862987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis.
    Karaoglan M; Nacarkahya G
    J Diabetes; 2021 Feb; 13(2):154-163. PubMed ID: 32710514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted next generation sequencing in patients with maturity-onset diabetes of the young (MODY).
    Özdemir TR; Kırbıyık Ö; Dündar BN; Abacı A; Kaya ÖÖ; Çatlı G; Özyılmaz B; Acar S; Koç A; Güvenç MS; Kutbay YB; Erdoğan KM
    J Pediatr Endocrinol Metab; 2018 Dec; 31(12):1295-1304. PubMed ID: 30447144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of ten causal genes in Turkish patients with clinically suspected maturity-onset diabetes of the young (MODY) using a targeted next-generation sequencing panel.
    Doğan M; Eröz R; Bolu S; Yüce H; Gezdirici A; Arslanoğlu İ; Teralı K
    Mol Biol Rep; 2022 Aug; 49(8):7483-7495. PubMed ID: 35733065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry.
    Johansson BB; Irgens HU; Molnes J; Sztromwasser P; Aukrust I; Juliusson PB; Søvik O; Levy S; Skrivarhaug T; Joner G; Molven A; Johansson S; Njølstad PR
    Diabetologia; 2017 Apr; 60(4):625-635. PubMed ID: 27913849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision Diagnosis of Maturity-Onset Diabetes of the Young with Next-Generation Sequencing: Findings from the MODY-IST Study in Adult Patients.
    Aydogan HY; Gul N; Demirci DK; Mutlu U; Gulfidan G; Arga KY; Ozder A; Camli AA; Tutuncu Y; Ozturk O; Cacina C; Darendeliler F; Poyrazoglu S; Satman I
    OMICS; 2022 Apr; 26(4):218-235. PubMed ID: 35333605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.